On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

A former defense secretary and congressman, he held the nation’s No. 2 job under President George W. Bush and was an ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today reported financial results for the third quarter of 2025 and recent business ...

Q3 2025 Press Conference Call November 6, 2025 4:00 AM ESTCompany ParticipantsAntonia Junelind - Senior Vice President ...

Skye Bioscience Inc (SKYE) reports encouraging phase 2A study outcomes but faces increased R&D expenses and net loss.

PSQ Holdings, Inc. (NYSE: PSQH) ("PublicSquare," or the "Company"), today reported financial results for the third quarter ...

Unisys reiterates full-year non-GAAP operating profit margin guidance and advances pension strategy with annuity purchase transaction. Total company revenue of $460.2 million, dow ...

Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the third quarter and nine-month period ended September 30, 2025. Discontinued operations as a ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today reported financial and operational results for the third quarter of ...

Plus: Cosette-Mayne deal hangs on Adelaide factory interest; Women-led groups dumped from $5m FemTech over pay row; ABC staff ...